Variant report
Variant | nsv581516 |
---|---|
Chromosome Location | chr2:40931058-40940311 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs181697039 | chr2:40939220-40939221 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs4101520 | chr2:40939221-40939222 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs186145357 | chr2:40939280-40939281 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs566469342 | chr2:40939291-40939292 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs189344407 | chr2:40939318-40939319 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs527345677 | chr2:40939319-40939320 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs181927892 | chr2:40939321-40939322 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs571879116 | chr2:40939392-40939393 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs7598736 | chr2:40939457-40939458 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs557607751 | chr2:40939463-40939464 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs569437261 | chr2:40939465-40939466 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs536753339 | chr2:40939492-40939493 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs554718494 | chr2:40939535-40939536 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs374540851 | chr2:40939545-40939546 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs144578807 | chr2:40939580-40939581 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs570785244 | chr2:40939620-40939621 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs116592666 | chr2:40939624-40939625 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs367793885 | chr2:40939627-40939628 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs576751143 | chr2:40939629-40939630 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs544067703 | chr2:40939664-40939665 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs562353272 | chr2:40939680-40939681 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs371206077 | chr2:40939707-40939708 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs537581182 | chr2:40939713-40939714 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs185913913 | chr2:40939728-40939729 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs541624973 | chr2:40939738-40939739 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs560032815 | chr2:40939746-40939747 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs527366818 | chr2:40939758-40939759 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs551911665 | chr2:40939782-40939783 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs190940220 | chr2:40939793-40939794 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs556218288 | chr2:40939820-40939821 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs532868702 | chr2:40939952-40939953 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs577787316 | chr2:40939984-40939985 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs551252881 | chr2:40940007-40940008 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs112794615 | chr2:40940015-40940016 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs553973193 | chr2:40940060-40940061 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs369084996 | chr2:40940067-40940068 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs141617123 | chr2:40940105-40940106 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs77987294 | chr2:40940122-40940123 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs534272141 | chr2:40940126-40940127 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs567533690 | chr2:40940146-40940147 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs558696698 | chr2:40940148-40940149 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs183259451 | chr2:40940171-40940172 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs544105796 | chr2:40940180-40940181 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs556088940 | chr2:40940195-40940196 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs574385172 | chr2:40940211-40940212 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs541695165 | chr2:40940212-40940213 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs186477644 | chr2:40940235-40940236 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs13017035 | chr2:40940248-40940249 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs572066888 | chr2:40940257-40940258 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs191776897 | chr2:40940266-40940267 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17393978 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Breast cancer | 17603634 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Bladder cancer | 21909424 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 19521722 | CNVD |
Autism | 18522746 | CNVD |
Non-small cell lung cancer | 18927303 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Prostate cancer | 21965145 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Neurocytoma | 17123091 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 21364760 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:40939200-40939800 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
2 | chr2:40939200-40939800 | Enhancers | HSMMtube | muscle |
3 | chr2:40939400-40940000 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
4 | chr2:40940000-40944200 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |